Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of November 23, 2024 • 12:00 AM ET

Date/Time Source News Release
11/12/2024 04:21 PM EST GlobeNewswire Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12/2024 08:00 AM EST GlobeNewswire Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma
10/10/2024 07:01 AM EDT GlobeNewswire Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial
10/10/2024 07:00 AM EDT GlobeNewswire Tempest Extends Limited Duration Stockholder Rights Plan
09/20/2024 04:30 PM EDT GlobeNewswire Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/18/2024 08:00 AM EDT GlobeNewswire Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
09/05/2024 08:00 AM EDT GlobeNewswire Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/23/2024 04:30 PM EDT GlobeNewswire Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/21/2024 08:00 AM EDT GlobeNewswire Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance
08/15/2024 08:00 AM EDT GlobeNewswire Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
Page

Additional News

As of November 23, 2024 • 12:00 AM ET

Date/Time Source News Release
11/12/2024 05:49 PM EST SeekingAlpha Tempest Therapeutics GAAP EPS of -$0.41 misses by $0.05
10/16/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Oct 16, 2024 as of 10.00 am ET
10/10/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Oct 10, 2024 as of 10.00 am ET
10/10/2024 07:51 AM EDT SeekingAlpha Roche collaboration for lead asset boosts Tempest
08/15/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Aug 15, 2024 as of 4:00 pm ET
08/15/2024 01:02 PM EDT SeekingAlpha Tempest jumps as FDA aligns with trial design for cancer drug
08/09/2024 03:05 AM EDT SeekingAlpha Tempest Therapeutics GAAP EPS of -$0.42 misses by $0.02
07/19/2024 05:12 PM EDT SeekingAlpha Tempest Therapeutics files for mixed shelf offering of up to $300M
06/20/2024 10:52 AM EDT SeekingAlpha Tempest falls after new trial data for liver cancer therapy
06/20/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Jun 20, 2024 as of 10.00 am ET
Page